How Bioactive Peptides Break Down in Blood — Improving Doping Detection in Horse Racing
Half of 27 protected bioactive peptides degraded in horse plasma, and identifying their breakdown products could improve doping detection.
Quick Facts
What This Study Found
Of 27 bioactive peptides with chemical protection at both ends (to resist degradation), 13 remained stable after 72 hours at body temperature in horse plasma. The other 14 broke down to varying degrees.
The researchers identified specific breakdown products (catabolites) for all 14 unstable peptides, including novel catabolites never previously reported for chemotactic peptide, DALDA, dmtDALDA, deltorphins I and II, and several dermorphin analogs.
Key stability rules emerged: a D-amino acid (mirror image of normal) at position 2 or position 1 of a peptide, or next to its C-terminus, protected that end from degradation. But a D-amino acid at position 3 did not help. N-terminal modifications like pyroglutamic acid or N-methylation did not protect the N-terminal end. A C-terminal ethylamide group did protect against carboxypeptidase attack. The C-terminal lysine amide in DALDA, dmtDALDA, and Lys7-dermorphin was unexpectedly vulnerable to plasma enzymes.
Key Numbers
27 peptides; 13 stable at 72h; 14 degraded; novel catabolites for 8 peptide types; D-amino acid position rules established
How They Did This
Researchers incubated 27 peptides in horse plasma under different conditions (temperature, time) and analyzed breakdown products using HILIC (a type of liquid chromatography) coupled with HRMS (high-resolution mass spectrometry). They predicted theoretical breakdown masses computationally, then confirmed them experimentally by their appearance over time and their fragmentation patterns.
Why This Research Matters
Peptide doping in horse racing is hard to detect because peptides break down quickly in blood. If testing labs only look for the intact peptide, they will miss it. Knowing the specific breakdown products means labs can test for those instead, catching cheaters who use peptides that would otherwise disappear before testing.
The Bigger Picture
Peptide doping is a growing challenge in equine and human sports. Traditional testing looks for the intact drug, but peptides break down quickly. This study enables detection of breakdown products, closing a significant gap in anti-doping testing capabilities.
What This Study Doesn't Tell Us
This tested peptide stability in horse plasma specifically, and degradation patterns may differ in human plasma or in vivo. The ex vivo (in a tube) conditions do not perfectly replicate what happens inside a living horse, where additional enzymes and clearance mechanisms are present. Only peptides with terminal protection were tested.
Questions This Raises
- ?Do these peptides break down similarly in human plasma?
- ?Can the breakdown product signatures be used to estimate when the peptide was administered?
- ?Are there additional undiscovered peptide doping agents not covered in this study?
Trust & Context
- Key Stat:
- 14 peptides degraded in plasma with identifiable breakdown products that can serve as new doping markers
- Evidence Grade:
- Moderate evidence. Rigorous analytical chemistry with validated methods, though tested only in horse plasma under ex vivo conditions.
- Study Age:
- Published in 2020. Anti-doping analytical methods continue to evolve with improved detection limits.
- Original Title:
- Identification of ex vivo catabolites of peptides with doping potential in equine plasma by HILIC-HRMS.
- Published In:
- Drug testing and analysis, 12(6), 771-784 (2020)
- Authors:
- Guan, Fuyu, Fay, Savannah, Li, Xiaoqing(2), You, Youwen, Robinson, Mary A
- Database ID:
- RPEP-04829
Evidence Hierarchy
Frequently Asked Questions
Why is peptide doping hard to detect?
Peptides break down quickly in blood, often disappearing before a test can be administered. By identifying the specific breakdown products, labs can detect doping even after the original peptide is gone.
Does this apply to human doping too?
The principles are the same, but human plasma may break down peptides differently. Additional validation in human samples would be needed.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-04829APA
Guan, Fuyu; Fay, Savannah; Li, Xiaoqing; You, Youwen; Robinson, Mary A. (2020). Identification of ex vivo catabolites of peptides with doping potential in equine plasma by HILIC-HRMS.. Drug testing and analysis, 12(6), 771-784. https://doi.org/10.1002/dta.2781
MLA
Guan, Fuyu, et al. "Identification of ex vivo catabolites of peptides with doping potential in equine plasma by HILIC-HRMS.." Drug testing and analysis, 2020. https://doi.org/10.1002/dta.2781
RethinkPeptides
RethinkPeptides Research Database. "Identification of ex vivo catabolites of peptides with dopin..." RPEP-04829. Retrieved from https://rethinkpeptides.com/research/guan-2020-identification-of-ex-vivo
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.